The objective of this review is to present the current evidence on APOE as a non-protagonist actor not just in the pathogenesis of major neurodegenerative diseases, such AD and dementia, but in the outcome and stratification of patients with PD, HD, acquired brain injury, coma, and DoC [6,7]. Here, APOE is linked to Parkinson disease.